Clinical Trial Update: Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)

View source ↗

Summary

This clinical trial registry reports on the long-term outcomes for HIV patients who participated in Phase 2 and 3 trials of Vicriviroc; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Vicriviroc (MK-7690)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Status: COMPLETED